These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Histomolecular profiling of pleomorphic, spindle cell, and giant cell carcinoma of the lung for targeted therapies. Forest F; Yvorel V; Karpathiou G; Stachowicz ML; Vergnon JM; Fournel P; Tiffet O; Trombert B; Péoc'h M Hum Pathol; 2016 Mar; 49():99-106. PubMed ID: 26826416 [TBL] [Abstract][Full Text] [Related]
4. Molecular genetic differentiation between primary lung cancers and lung metastases of other tumors. Kandioler D; Dekan G; End A; Pasching E; Buchmayer H; Gnant M; Langmann F; Mannhalter C; Eckersberger F; Wolner E J Thorac Cardiovasc Surg; 1996 Apr; 111(4):827-31; discussion 832. PubMed ID: 8614143 [TBL] [Abstract][Full Text] [Related]
5. Applications and limitations of immunohistochemical expression of "Napsin-A" in distinguishing lung adenocarcinoma from adenocarcinomas of other organs. Kadivar M; Boozari B Appl Immunohistochem Mol Morphol; 2013 May; 21(3):191-5. PubMed ID: 22914608 [TBL] [Abstract][Full Text] [Related]
6. Molecular profiling of lung adenosquamous carcinoma: hybrid or genuine type? Vassella E; Langsch S; Dettmer MS; Schlup C; Neuenschwander M; Frattini M; Gugger M; Schäfer SC Oncotarget; 2015 Sep; 6(27):23905-16. PubMed ID: 26068980 [TBL] [Abstract][Full Text] [Related]
7. Intestinal adenosquamous carcinoma with a synchronous skin metastasis: a immunohistochemical and molecular analysis. Parente P; Covelli C; Parrella P; Latiano TP; Fiordelisi F; Pellico MT; Maiello E; Graziano P Int J Colorectal Dis; 2020 Feb; 35(2):337-341. PubMed ID: 31823050 [TBL] [Abstract][Full Text] [Related]
8. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies. Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187 [TBL] [Abstract][Full Text] [Related]
9. [Renal metastasis originating from pulmonary carcinoma: a case report]. Uemura M; Hirai T; Inoue H; Kanno N; Nishimura K; Mizutani S; Miyoshi S; Yoshida K; Kawano K; Matsumura A Hinyokika Kiyo; 2001 Jul; 47(7):489-92. PubMed ID: 11523134 [TBL] [Abstract][Full Text] [Related]
10. Detection of PIK3CA mutations, including a novel mutation of V344G in exon 4, in metastatic lung adenocarcinomas: A retrospective study of 115 FNA cases. Allison DB; Lilo MT; Geddes S; Pallavajjalla A; Askin F; Gabrielson E; Zheng G; Li QK Cancer Cytopathol; 2016 Jul; 124(7):485-92. PubMed ID: 27007084 [TBL] [Abstract][Full Text] [Related]
11. [Three cases of metastatic renal tumor]. Mori N; Tei N; Kakimoto K; Hara T; Koide T Hinyokika Kiyo; 1999 May; 45(5):343-7. PubMed ID: 10410318 [TBL] [Abstract][Full Text] [Related]
12. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC). Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301 [TBL] [Abstract][Full Text] [Related]
13. Mutational Diversity of Lung Cancer and Associated Lymph Nodes. An Exploratory Prospective Study of 4 Resected cIIIA-N2. Legras A; Roussel H; Mangiameli G; Arame A; Grand B; Pricopi C; Badia A; Gibault L; Badoual C; Fabre E; Laurent-Puig P; Blons H; Le Pimpec-Barthes F Pathol Oncol Res; 2019 Jan; 25(1):319-325. PubMed ID: 29110262 [TBL] [Abstract][Full Text] [Related]
14. Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening-Detected Lung Cancers. Verri C; Borzi C; Holscher T; Dugo M; Devecchi A; Drake K; Sestini S; Suatoni P; Romeo E; Sozzi G; Pastorino U; Boeri M J Thorac Oncol; 2017 Jun; 12(6):922-931. PubMed ID: 28302568 [TBL] [Abstract][Full Text] [Related]
15. Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. Leong PP; Rezai B; Koch WM; Reed A; Eisele D; Lee DJ; Sidransky D; Jen J; Westra WH J Natl Cancer Inst; 1998 Jul; 90(13):972-7. PubMed ID: 9665144 [TBL] [Abstract][Full Text] [Related]
16. Tracking the origin of simultaneous endometrial and ovarian cancer by next-generation sequencing - a case report. Valtcheva N; Lang FM; Noske A; Samartzis EP; Schmidt AM; Bellini E; Fink D; Moch H; Rechsteiner M; Dedes KJ; Wild PJ BMC Cancer; 2017 Jan; 17(1):66. PubMed ID: 28103826 [TBL] [Abstract][Full Text] [Related]
17. Detection of EML4-ALK fusion genes in non-small cell lung cancer patients with clinical features associated with EGFR mutations. Shaozhang Z; Xiaomei L; Aiping Z; Jianbo H; Xiangqun S; Qitao Y Genes Chromosomes Cancer; 2012 Oct; 51(10):925-32. PubMed ID: 22736493 [TBL] [Abstract][Full Text] [Related]
18. Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma. Rachiglio AM; Esposito Abate R; Sacco A; Pasquale R; Fenizia F; Lambiase M; Morabito A; Montanino A; Rocco G; Romano C; Nappi A; Iaffaioli RV; Tatangelo F; Botti G; Ciardiello F; Maiello MR; De Luca A; Normanno N Oncotarget; 2016 Oct; 7(41):66595-66605. PubMed ID: 27448974 [TBL] [Abstract][Full Text] [Related]
19. Pulmonary enteric adenocarcinoma indistinguishable morphologically and immunohistologically from metastatic colorectal carcinoma. László T; Lacza A; Tóth D; Molnár TF; Kálmán E Histopathology; 2014 Aug; 65(2):283-7. PubMed ID: 24571601 [No Abstract] [Full Text] [Related]
20. [The third primary-the second metachronous lung cancer in the same patient]. Fındık G; Hazer S; Aydoğdu K; Küçükbayrak A; Kaya S Tuberk Toraks; 2012; 60(4):365-9. PubMed ID: 23289467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]